Updated

Updated · Newsweek · Jul 1

Utah Study Finds Arc Protein Drives Alzheimer's Tau Spread, Opening 1 New Treatment Target

Updated

Updated · Newsweek · Jul 1

Utah Study Finds Arc Protein Drives Alzheimer's Tau Spread, Opening 1 New Treatment Target

Q: A new therapy might trap Alzheimer's toxins. How soon could this halt the disease before it infects more brain cells?

Not soon. The approach is still at an early, preclinical stage, and there is no timeline yet for when it could be used in patients. The new study, published in *Cell*, shows in mice that toxic Tau spreads by hitching a ride in extracellular vesicles with the help of the Arc protein. When Arc was removed, Tau transfer between neurons fell by about 99%, strongly suggesting that blocking these Tau-carrying vesicles could slow or stop further spread to healthy brain cells. But researchers stress that this is not yet a treatment. Most of the work was done in mouse models, with supporting evidence from human brain tissue, and scientists say they are still far from developing a therapy for people. A major challenge is that Arc is not simply harmful: it also appears to protect stressed neurons early in disease by helping them expel excess Tau. That means any therapy would likely need to intercept toxic vesicles after they leave a sick cell, without disrupting Arc’s normal role in memory and synaptic function. In practical terms, even if the mechanism holds up in humans, a drug based on it would still need years of lab work, safety testing, and clinical trials. So the realistic answer is that this strategy is promising as a future way to slow Alzheimer’s progression, especially early on, but it is not expected to halt the disease in patients anytime soon.

3 articles · Updated · Newsweek · Jul 1

University of Utah Health researchers found the Arc protein ferries toxic Tau from damaged neurons into healthy ones, identifying a mechanism that may help Alzheimer's spread through the brain.
Mouse experiments showed Arc packages Tau into extracellular vesicles; when Arc was removed, those vesicles carried far less Tau and neuron-to-neuron spread dropped sharply.
The finding complicates treatment design because Arc also seems to help stressed neurons survive early in disease by expelling excess Tau, making a full blockade potentially harmful.
Human brain tissue also contained vesicles carrying both Arc and Tau, suggesting the same pathway may operate in people, though researchers said much more human study is needed.
Published in Cell on June 29, the work points to therapies that intercept Tau-bearing vesicles before they enter healthy neurons, aiming to slow progression rather than just clear protein buildup.

Sources

Newsweek16d ago

University of Utah Health Identifies Arc Protein's Role in Alzheimer's Spread

Neuroscience News17d ago

Arc Protein Found to Spread Toxic Tau in Alzheimer's - Neuroscience News

ScienceDaily17d ago

University of Utah Health Scientists Identify Arc Protein as Key to Alzheimer's Tau Spread

4 Sources

A new therapy might trap Alzheimer's toxins. How soon could this halt the disease before it infects more brain cells?

If a brain protein helps spread Alzheimer's like a virus, could antiviral-style drugs be the key to a cure?

Arc Protein Drives Tau Spread in Alzheimer’s: New Mechanism, Therapeutic Targets, and the Shift Beyond Amyloid

Overview

Recent research has revealed that the Arc protein, essential for memory and healthy brain function, plays a surprising role in the spread of Alzheimer’s disease. Normally, Arc helps neurons communicate by packaging itself into tiny sacs called extracellular vesicles (EVs). In Alzheimer’s, however, toxic tau proteins hitch a ride inside these Arc-containing EVs. This allows tau to move from diseased to healthy neurons, where it triggers new tau buildup and helps the disease spread through the brain. Understanding this process opens new possibilities for stopping Alzheimer’s progression by targeting how tau is transmitted.

...